Heskumdai if youre correct about Roche then maybe we havent seen anything yet as far as low sp goes. if roche cant find anything of use from the huge number of peptides available then the whole library looks a little impotent. I would think that the way Nick goes in talking up a storm they would probably get a go from a few top bios as what do they have to lose but a some pocket change to them. Once one company drops them others might start to look a bit closer. Bearing in mind dr Watts i think it is ? is off in the UK on various other projects and all the directors seem to be pretty safe if everything fails as is usually the case.
no news is not good news, page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $125.5K | 667.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11936 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 40292 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |